bimekizumab
ucb pharmaceuticals
['bimekizumab', 'axspa']
interesting data concerning efficacy bimekizumab (antiil17a/f) in nr-axspa. bmk is as efficient in tnf-ir patients as tnf na ve ones! same results in other studies with bmk (r-axspa/psa/pso)
#acr2022 
MD Rheumato @CHRUStrasbourg Therapist @cnet_therap Member of @EMEUNET subcommittee PhD at @i2ctibmc